HIGHLIGHTS
- who: Yuichi Ichinose from the patients in JapanThe University have published the research work: Imatinib use for gastrointestinal stromal tumors among older patients in Japan and Taiwan, in the Journal: Scientific Reports Scientific Reports of December/31,/2014
- what: Given the longer follow-up period in this study, the authors solicited the hospitals to provide follow-up data up to 2018. The study focused on high-risk GIST patients who received imatinib because the authors aimed to describe the patterns of imatinib use.
- how: The DPC data were collected on a routine basis . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.